Prostate cancer is one of the most common cancers in men which can be managed with several available options for localized disease such as (i) active surveillance, (ii) surgery, (iii) radical prostatectomy, (v) radiotherapy, (vi) radiofrequency ablation, (vii) cryotherapy, (viii) stereotactic ablative radiotherapy, (ix) focal therapy, (x) proton therapy, and (xi) brachytherapy. Among these options multiple competing treatment modalities are often equally effective but can have variable side effects and cost.

The purpose of this special issue is to publish high-quality research papers as well as review articles addressing recent advances in diagnosis, treatment, clinical outcomes, scientific findings, and technological developments. Original and high-quality contributions that are not yet published or not currently under review by other journals or peer-reviewed conferences are invited for submission.

Potential topics include, but are not limited to:

• Multimodal and multiparametric imaging
• New radiotherapy techniques
• Advances in patient immobilization
• SBRT/ SABR
• IGRT and adaptive radiation therapy
• LDR, PDR, and HDR brachytherapy
• Selective and focal radiation therapy
• Proton/ particle therapy
• Robotic-assistance in IMRT/SBRT and brachytherapy
• Toxicity and clinical outcomes
• Patient safety and quality of treatment evaluation or methods for RT of prostate cancer